Leadership team

Jeremie Trochu

Jeremie joined Ardena as our new Chief Executive Officer in June 2024.

He brings an extensive knowledge of the life sciences and CDMO industry, and a proven track record of success in the biopharma sector, with 20 years of experience building and growing businesses globally, expanding into new markets, and leading large-scale transformations in both publicly traded and privately held companies.

Jeremie was previously part of the team that helped transform Catalent from a private equity spinoff into a publicly traded global CDMO, and during his tenure there, led the successful acquisition and integration of multiple companies.

Filip Van Herck, CPA

Filip assumed the role of Chief Financial Officer at Ardena in October 2017. Prior to his appointment, he held various positions at Capsugel (following its spin-out from Pfizer) and Lonza (after its acquisition of Capsugel). He was responsible for overseeing the coordination of IPO readiness efforts and the integration of finance departments following the Lonza-Capsugel acquisition. Earlier in his career, Filip worked at Cisco, where he held several financial positions of increasing responsibility. He obtained a degree in Applied Economics from the University of Leuven in Belgium, and a degree in Business Studies from the Michael Smurfit Business School in Ireland. Filip is a Certified Public Accountant (AICPA).

Gerjan Kemperman, PhD

Gerjan has significant leadership experience with 15+ years in the pharma industry. He worked previously at Organon/MSD in various leadership roles. Gerjan co-founded ChemConnection in 2012. He successfully led and grew the company and finally managed its buyout to Mentha Capital in 2018.

Ariane De Ganck, PhD

Since 2019, Ariane has overseen Ardena’s drug product activities, spearheading successful integration and transformation at Ardena Pamplona and expanding the company’s capabilities to include sterile services.

Gunnar Flik, PhD

Gunnar Flik joined Ardena in 2024 as Division Head of Bioanalytical Services. With over 20 years of experience in drug discovery within biotech and CRO environments, Gunnar brings a wealth of strategic vision and entrepreneurial expertise to his role. He is dedicated to developing comprehensive short- and long-term strategic plans aimed at optimizing efficiency, fostering growth, and enhancing profitability within Ardena’s Bioanalysis division.

Ian Bilodeau

Ian joined Ardena in 2025 as US Managing Director.  He has over 30 years of global experience across multiple functions in both the CDMO and Medical device industry.   Ian spent 19 years of his career working at GE in Quality, Finance, Supply Chain, Technical services and Commercial operations.   He then joined Catalent in 2013 where he was VP of Sales Operations and more recently GM for the Somerset site.  He holds degree in Mechanical Engineering and an MBA from Northwestern University – Kellogg School of Management.